The Biden Administration has declared its intention to end the COVID-19 public health emergency (PHE) on May 11, 2023. There will be a 90-calendar day transition period which will expire at 11:59 p.m. on August 9, 2023. The PHE was put in place when the pandemic began, offering numerous flexibilities to help doctors and patients cope during the unprecedented times.
While certain telehealth waivers will remain in place after PHE ends, many leniencies will either change or stop. Some of these changes will take place right away, some after the 2023 calendar year ends, and others after 2024. In order to help you stay fully compliant with the pending transition, here is a timeline and several important takeaways of what is to come.
During the pandemic, the Centers for Medicare & Medicaid Services (CMS) increased reimbursements for telehealth services in non-facility settings (for example, a patient’s residence), bringing those costs in line with payments for in-person treatments. Once the PHE ends, telehealth rates should likely return to pre-pandemic levels.
The Ryan Haight Act of 2008 was put in force to prohibit the prescription of controlled substances over the internet. It required the prescribing practitioner to first conduct at least one in-person medical evaluation. This stipulation was waived during the pandemic, allowing patients to bypass the step and receive their medication through telemedicine.
After the PHE ends, the in-person treatment requirement will be reinstated. If a patient has never been seen in-person by their prescriber (meaning that the patient started their treatment remotely, after the PHE was initiated), then the patient will no longer be able to receive certain prescriptions without first seeing their provider in person. Patients unable to visit their provider in person may have to transfer care to a local provider.
During the PHE, health care providers were not subject to administrative sanctions under the federal Anti-Kickback Statute or the Civil Monetary Penalty and exclusion laws for reducing or waiving cost-sharing amounts (such as copayments or deductibles) for telehealth services or remote patient monitoring (RPM) services.
After the public health emergency, health care providers delivering telehealth or RPM services to Medicare beneficiaries may no longer decrease or waive cost-sharing requirements for such services. Thus, digital health companies will need to ensure they have a mechanism in place to make sure these fees are both charged and collected.
During the pandemic, the CMS waived the “established patient” requirement which allowed for practitioners to bill for RPM for new patients. Moving forward, RPM Services will once again be limited only to "established patients." Physicians will first have to conduct new patient evaluation and management service before rendering RPM services.
During the PHE, providers were able to employ telehealth in good faith, even if their platforms or software did not comply with Health Insurance Portability and Accountability Act (HIPAA) regulations.
Starting August 10th, the Office for Civil Rights (OCR) will commence enforcing fines against providers for noncompliance with HIPAA laws regarding technology usage.
After the 2023 calendar year, virtual direct supervision is scheduled to end.
During the PHE, direct supervision rules were altered to allow for remote supervision using real-time audio-visual technology. After the 2023 calendar year, this permission is set to end.
Thanks to the Consolidated Appropriations Act (CAA) of 2023, the following telehealth flexibilities will remain in place through the end of 2024:
To stay up to date, check out our other blogs and follow TherapyNotes® on Facebook, Instagram, LinkedIn, Twitter & TikTok! We're also available by phone 7 days a week- give us a call! (215) 658-4550.
Affairs (ASPA), Assistant Secretary for Public. “Fact Sheet: COVID-19 Public Health Emergency Transition Roadmap.” HHS.gov, 9 Feb. 2023, www.hhs.gov/about/news/2023/02/09/fact-sheet-covid-19-public-health-emergency-transition-roadmap.html.
"SAP - H.R. 382: A bill to terminate the public health emergency declared with respect to COVID-19; H.J. Res. 7: A joint resolution relating to a national emergency declared by the President on March 13, 2020." Whitehouse.gov, Statement of Administration Policy, 30 January 2023. https://www.whitehouse.gov/wp-content/uploads/2023/01/SAP-H.R.-382-H.J.-Res.-7.pdf?.
* The content of this post is intended to serve as general advice and information. It is not to be taken as legal advice and may not account for all rules and regulations in every jurisdiction. For legal advice, please contact an attorney.